immune
Jan 16, 2019
Highly mutated cancers respond better to immune therapy
A survey was done in which thousands of advanced cancers indicated a way to detect those that respond to revolutionary therapies that unleash an immune response against tumours. However, the results show difficulty level to translate an approach into a reliable clinical test. The findings are the latest evidence to...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
